 | • レポートコード：B-MOR-05186 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、エピジェネティクス（後生学）の世界市場について調べ、エピジェネティクス（後生学）の世界規模、市場動向、市場環境、キット別分析、試薬別分析、酵素別分析、器具別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・エピジェネティクス（後生学）の世界市場インサイト ・エピジェネティクス（後生学）の世界市場環境 ・エピジェネティクス（後生学）の世界市場動向 ・エピジェネティクス（後生学）の世界市場規模 ・エピジェネティクス（後生学）の世界市場規模：キット別 ・エピジェネティクス（後生学）の世界市場規模：試薬別 ・エピジェネティクス（後生学）の世界市場規模：酵素別 ・エピジェネティクス（後生学）の世界市場規模：器具別 ・エピジェネティクス（後生学）の世界市場規模：用途別 ・エピジェネティクス（後生学）の世界市場：地域別市場規模・分析 ・エピジェネティクス（後生学）の北米市場規模・予測 ・エピジェネティクス（後生学）のアメリカ市場規模・予測 ・エピジェネティクス（後生学）のヨーロッパ市場規模・予測 ・エピジェネティクス（後生学）のアジア市場規模・予測 ・エピジェネティクス（後生学）の日本市場規模・予測 ・エピジェネティクス（後生学）の中国市場規模・予測 ・エピジェネティクス（後生学）のインド市場規模・予測 ・エピジェネティクス（後生学）の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global epigenetics market is estimated to grow rapidly at a CAGR of over 20% during the forecast period. Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions.
Increasing Incidence and Prevalence of Cancer
According to Cancer Research UK, in 2012, 14.1 million new cases of cancer were diagnosed worldwide. The World Health Organization estimated that this figure may rise to 35 million new cases in 2035. It is also estimated that nearly 550,000 new cases are diagnosed with head and neck cancer each year, across the world. It is estimated that nearly 6% of the malignancies occur in the United States. According to the American Cancer society, nearly 40,000 people in the United States are diagnosed with head and neck cancer, of which 12,000 were supposed to die in the year 2014 alone. This depicts the large patient pool of cancer patients, which will propel the growth of the epigenetics market. The other factors, like increasing funding for R&D in healthcare and the rising epigenetic applications in non-oncology diseases, are driving the market.
Rising Cost of Instruments
The epigenetic instruments cost is rising gradually, and this increase is becoming one of the major restrains for the growth of the market. The instruments, such as mass spectrometers, sonicators, and the next generation sequences, are already costly, and the rising cost of these instruments are going to increase the cost for the genetic test, which simultaneously decreases the adoption rate of epigenetics. And the lack of skilled researchers is restraining the market growth of epigenetics.
The United States has the Highest Market Share
In North America, the United States is dominating the epigenetics market due to the factors, such as increasing prevalence rate of cancer, increasing funding for the R&D, and the increasing collaborations between several large pharmaceutical companies for development of enhanced therapeutics. Asia-Pacific is expected to record a substantial growth over the forecast period.
Key Developments in the Market
• December 2017: Roche and Ignyta made definitive merger agreement
• December 2017: Zymo Research collaborated with Bertin
Major Players: ABCAM PLC, ACTIVE MOTIFF, DIAGENODE INC, ILLUMINA INC, MERCK & CO., QIAGEN, SIGMA ALDRICH CORPORATION, THERMO FISHER SCIENTIFIC, ZYMO RESEARCH CORPORATION, and ROCHE, amongst others
Reasons to Purchase the Report
• Current and future market outlook for epigenetics in the developed and emerging markets
• Analyze various perspectives on the market, with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Incidence and Prevalence of Cancer
6.1.2 Increasing Funding for R&D in Healthcare
6.1.3 Rising Epigenetic Applications in Non-Oncology Diseases
6.2 Market Restraints
6.2.1 Rising Cost of Instruments
6.2.2 Dearth of Skilled Researchers
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 Segmentation -by Kits
7.1.1 Bisulfite Conversion Kits
7.1.2 Chip-seq Kits
7.1.3 RNA Sequencing Market
7.1.4 Whole Genome Amplification Market
7.1.5 5-HMC and 5-MC Analysis Kits
7.1.6 Other Kits
7.2 Segmentation -by Reagents
7.2.1 Antibodies
7.2.2 Buffers
7.2.3 Histones
7.2.4 Magnetic Beads
7.2.5 Primers
7.2.6 Other Reagents
7.3 Segmentation -by Enzymes
7.3.1 DNA – Modifying Enzymes
7.3.2 Protein Modifying Enzymes
7.3.3 RNA Modifying Enzymes
7.4 Segmentation -by Instruments
7.4.1 Mass Spectrometer
7.4.2 Sonicators
7.4.3 Next Generation Sequencers
7.4.4 Others
7.5 Segmentation -by Application
7.5.1 Oncology
7.5.2 Non-Oncology
7.5.2.1 Inflammatory Diseases
7.5.2.2 Metabolic Diseases
7.5.2.3 Infectious Diseases
7.5.2.4 Cardiovascular Diseases
7.5.2.5 Others
7.5.3 Developmental Biology
7.5.4 Other Research Areas
7.6 Segmentation -by Technology
7.6.1 DNA Methylation
7.6.2 Histone Methylation
7.6.3 Histone Acetylation
7.6.4 Large Noncoding RNA
7.6.5 MicroRNA modification
7.6.6 Chromatin Structures
7.7 Segmentation – by Geography
7.7.1 North America
7.7.1.1 United States
7.7.1.2 Canada
7.7.1.3 Mexico
7.7.2 Europe
7.7.2.1 France
7.7.2.2 Germany
7.7.2.3 United Kingdom
7.7.2.4 Italy
7.7.2.5 Spain
7.7.2.6 Rest of Europe
7.7.3 Asia-Pacific
7.7.3.1 China
7.7.3.2 Japan
7.7.3.3 India
7.7.3.4 Australia
7.7.3.5 New Zealand
7.7.3.6 South Korea
7.7.3.7 Rest of Asia-Pacific
7.7.4 Middle East & Africa
7.7.4.1 GCC
7.7.4.2 South Africa
7.7.4.3 Rest of Middle East & Africa
7.7.5 South America
7.7.5.1 Brazil
7.7.5.2 Argentina
7.7.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 Abcam PLC
9.2 Active Motiff
9.3 Diagenode Inc.
9.4 Illumina Inc.
9.5 Merck & Co.
9.6 Qiagen
9.7 Sigma Aldrich Corporation
9.8 Thermo Fisher Scientific
9.9 Zymo Research Corporation
9.10 Roche
9.11 Others
10. Future of the Market